HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $36 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.6%

Neg 0% Neu 87.6% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $36 price target.